Search

everythinglearnresearchcommunity

for

Search:↓

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Glycyrrhizin nanocarriers effectively deliver baicalin to hair follicles, promoting hair growth and offering a promising alopecia treatment with fewer side effects.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Some people with schwannomatosis have a new type of mutation in the LZTR1 gene.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

Researchers developed a scaffold that releases a healing drug over time, improving wound healing and skin regeneration.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Freeze-drying collagen-activated PRP increases TGF-β1 levels, enhancing tissue regeneration potential.

Type II spiral ganglion neurites avoid high concentrations of laminin and fibronectin.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

A genetic marker linked to a type of hair loss was found in most patients studied.

Tofacitinib may help treat severe hair loss, but more research is needed.

The new drug delivery system effectively targets lung cancer cells.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Mutations in specific llama genes may affect fiber quality for textiles.